Article Information
History
- May 2, 2021.
Article Versions
- You are currently viewing Version 1 of this article (May 2, 2021 - 19:19).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sarah Herberg1,#,
- Yoshitaka Fujihara2,3,#,
- Andreas Blaha1,4,
- Karin Panser1,
- Kiyonari Kobayashi2,
- Tamara Larasati2,
- Maria Novatchkova1,
- H. Christian Theußl1,
- Olga Olszanska1,
- Masahito Ikawa2,5,6,7,* and
- Andrea Pauli1,*
- 1Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Campus-Vienna-Biocenter 1, 1030 Vienna, Austria
- 2Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan
- 3Department of Bioscience and Genetics, National Cerebral and Cardiovascular Center, Suita, Osaka 564-8565, Japan
- 4Vienna BioCenter PhD Program, Doctoral School of the University at Vienna and Medical University of Vienna, Vienna, Austria
- 5Immunology Frontier Research Center, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan
- 6Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan
- 7The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan
- ↵*corresponding authors, Contact details for corresponding authors: ikawa{at}biken.osaka-u.ac.jp, andrea.pauli{at}imp.ac.at
↵# equal contribution